About Simson Pharma Limited
Data last updated:
Simson Pharma Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the online healthcare product retail segment of the e-commerce sector. It was incorporated on 19 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2018PLC308280. Its GSTIN is 27ABACS1984P1ZO (Maharashtra). The company holds 4 GST registrations, all of them active.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹9.99 Cr. It is led by directors including Satyanarayana Rao Penchala (Managing Director) and Manga Rani Penchala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gala No – B/307 3rd Floor New Sarita Bldg. Prabhat Indl Complex Dahisar East, Mumbai, Maharashtra, India – 400068.
As per the financials filed for FY 2025, the company reported a revenue of ₹93.36 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹19.33 Cr (net margin 20.7%) and EBITDA of ₹29.55 Cr (EBITDA margin 31.7%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 20% over five years.
The company has about 218 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Simson Pharma Limited. As per MCA filings, the company has open charges of ₹1.25 Cr on record. Court records list 7 cases involving the company, including 6 filed by the company and 1 filed against it; 4 cases are pending.
For more details, the company can be reached via its website simsonpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressGala No – B/307 3rd Floor New Sarita Bldg. Prabhat Indl Complex Dahisar East, Mumbai, Maharashtra, India – 400068
- IndustryE-Commerce, Online Healthcare Product Retail
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Simson Pharma Limited
The main business activity of Simson Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Simson Pharma Limited FY 2025 filings available
Simson Pharma Limited reported revenue of ₹93.36 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Simson Pharma Limited
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 10% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Simson Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹29.55 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹19.33 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Simson Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 31.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 20.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Simson Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Simson Pharma Limited
Simson Pharma Limited is compared with the companies closest to it by revenue in the Ecommerce and Internet industry (Healthcare Products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cure and Care Wellness Private Limited | ₹107.96 Cr (FY 2025) | •••• | •••• | 34.0% | •••• | Bangalore, Karnataka, India |
| Jovees Herbal Care India Limited | ₹105.54 Cr (FY 2024) | •••• | •••• | 21.0% | •••• | Noida, Uttar Pradesh, India |
| Nutrabay Retail Private Limited | ₹100.23 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | New Delhi, Delhi, India |
| Apcos Naturals Private Limited | ₹98.93 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Mohali, Punjab, India |
| Chemist Box Private Limited | ₹97.63 Cr (FY 2025) | •••• | •••• | 51.0% | •••• | Patna, Bihar, India |
| Simson Pharma Limited this company | ₹93.36 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| Aeronutrix Sports Products Private Limited | ₹81.55 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Mumbai, Maharashtra, India |
| Theryco Healthcare Solutions Private Limited | ₹78.67 Cr (FY 2025) | •••• | •••• | 105.0% | •••• | Mumbai, Maharashtra, India |
| Axelia Solutions Private Limited | ₹75.48 Cr (FY 2025) | •••• | •••• | -27.0% | •••• | Mumbai, Maharashtra, India |
| Curebay Technologies Private Limited | ₹70.41 Cr (FY 2025) | •••• | •••• | 467.0% | •••• | Bhubaneswar, Odisha, India |
| Gynoveda Femtech Private Limited | ₹68.14 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Simson Pharma by revenue in the Ecommerce and Internet industry (Healthcare Products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Simson Pharma Limited
Simson Pharma Limited is audited by JMR & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| JMR & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Simson Pharma Limited
Simson Pharma has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manga Rani Penchala | Director | 19 Apr 2018 | 8 Years 5 Months | Current |
| Bhavika Penchala | Director | 19 Apr 2018 | 8 Years 5 Months | Current |
| Satyanarayana Rao Penchala | Managing Director | 19 Apr 2018 | 8 Years 5 Months | Current |
| Sonit Sai Penchala Also directs: Healthtech Solutions Private Limited, Amma Ayee Seva Foundation | Director | 14 Aug 2025 | 1 Years 2 Months | Current |
Ownership and Shareholding of Simson Pharma Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Simson Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Oct 2023 | Idbi Bank Limited | ₹1.25 Cr | Open |
Total charge records: 1 View all charges
Legal Cases of Simson Pharma Limited
Simson Pharma Limited has 7 court cases on record: 6 filed by Simson Pharma, 1 filed against it. 4 cases are pending and 3 are disposed. Status as checked between 21 Sep 2026 and 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 1 | 4 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against Bioradius Therapeutic Research Private Limited | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against Optimus Drugs Private Limited | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against Orginpulse Pharmaceuticals Private Limited | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against an individual | Pending |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Appln.PGA) | Filed against the company by an individual | Disposed |
Full case history
All 7 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Simson Pharma Limited
Simson Pharma Limited has 13 MSME Form 1 returns on record between 2019 and 2023, listing 1,865 overdue payments to 30 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 30)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Simson Life Sciences Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| First Source Laboratory Solutions LLP | •••• | •••• | •••• |
| C.Abhaykumar & Co. | •••• | •••• | •••• |
| GBS Lifesciences LLP | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 13 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Simson Pharma Limited
Simson Pharma operates one associated brand: Simson Pharma Limited. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Supply of research chemicals and pharmaceutical standards in India. | simsonpharma.com |
Employees and EPFO Compliance at Simson Pharma Limited
Simson Pharma Limited has a workforce of 218 employees as of Apr 02, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Simson Pharma Limited
Simson Pharma Limited has 4 board changes on record since 2018: 4 appointments. The latest: Sonit Sai Penchala was appointed as Director on 14 Aug 2025.
Credit Ratings, Litigation & Regulatory Alerts for Simson Pharma Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Simson Pharma Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Simson Pharma Limited
Simson Pharma has 4 GST registrations: 4 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABACS1984P1ZO | Maharashtra | Active | 01 Jun 2018 |
| 27ABACS1984P2ZN | Maharashtra | Active | 01 Apr 2025 |
| 24ABACS1984P1ZU | Gujarat | Active | 14 Feb 2023 |
| 36ABACS1984P1ZP | Telangana | Active | 01 May 2025 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Simson Pharma Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Simson Pharma Limited
Simson Pharma is an active public limited company based in Mumbai, Maharashtra, India. The company works in online healthcare product retail, within the e-commerce industry. It was incorporated on 19 April 2018 (8+ years old) and is registered under CIN U24230MH2018PLC308280.
Simson Pharma reported revenue of ₹93.36 Cr for FY 2025 (up 10% YoY).
Simson Pharma has 4 current directors:
- Satyanarayana Rao Penchala - Managing Director
- Manga Rani Penchala - Director
- Bhavika Penchala - Director
- Sonit Sai Penchala - Director
Simson Pharma reported a net profit of ₹19.33 Cr (net margin 20.7%) and EBITDA of ₹29.55 Cr (EBITDA margin 31.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Simson Pharma is 16% over three years and 20% over five years. In the latest year (FY 2025) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Simson Pharma is 27ABACS1984P1ZO, registered in Maharashtra. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 27ABACS1984P2ZN (Maharashtra), 24ABACS1984P1ZU (Gujarat), 36ABACS1984P1ZP (Telangana).
The CIN (Corporate Identification Number) of Simson Pharma is U24230MH2018PLC308280. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Simson Pharma has 7 court cases on record: 6 filed by the company and 1 filed against it. 4 are pending.
Simson Pharma was incorporated on 19 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Simson Pharma by revenue are Cure and Care Wellness Private Limited, Jovees Herbal Care India Limited, Nutrabay Retail Private Limited, Apcos Naturals Private Limited, Chemist Box Private Limited and 5 more, all in the Ecommerce and Internet industry (Healthcare Products).
Sonit Sai Penchala was appointed as Director on 14 Aug 2025. Bhavika Penchala was appointed as Director on 19 Apr 2018. Manga Rani Penchala was appointed as Director on 19 Apr 2018. Simson Pharma has 4 board changes on record in total.
Simson Pharma has 13 MSME Form 1 returns on record between 2019 and 2023, listing 1,865 overdue payments to 30 micro and small suppliers. The latest return was filed on 21 Nov 2023.